GenomeWeb January 11, 2022
Staff reporter

NEW YORK – The 40th Annual JP Morgan Healthcare Conference kicked off on Monday, as conference organizers pivoted to a virtual conference instead of the usual live event at the Westin St. Francis Hotel in San Francisco due to the resurgent coronavirus pandemic. Nonetheless, the conference got off to its normal busy start with several diagnostics and genomic tools firms making their case to investors. Below are brief reports on individual presentations webcast by the companies or through the JP Morgan conference portal.

Omid Farokhzad, Seer’s chairman and CEO, announced during his presentation that the company has started broad commercial sales of its Proteograph proteomics platform and that it has booked “multiple orders” thus far.

This follows a...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Conferences / Podcast, Pharma / Biotech, Trends
Brazil’s plan for low-cost CAR-Ts
PacBio’s Repeat Expansion Panel, Owkin-Sanofi AI Take on Immunology, More
STAT+: Borrowing an idea from cancer immunotherapy, scientists make old-mice immune systems youthful again
Moderna gets Blackstone backing for flu vaccine R&D
FDA Approves Winrevair, Merck’s Novel Treatment for Pulmonary Arterial Hypertension

Share This Article